Høgdall CK - Search Results

1

Common filaggrin gene mutations and risk of cervical cancer.

Bager P, Wohlfahrt J, Sørensen E, Ullum H, Høgdall CK, Palle C, Husemoen LL, Linneberg A, Kjaer SK, Melbye M, Thyssen JP. Bager P, et al. Among authors: hogdall ck. Acta Oncol. 2015 Feb;54(2):217-23. doi: 10.3109/0284186X.2014.973613. Epub 2014 Nov 10. Acta Oncol. 2015. PMID: 25383447

2

Prognostic value of serum tetranectin in patients with metastatic breast cancer.

Høgdall CK, Sölétormos G, Nielsen D, Nørgaard-Pedersen B, Dombernowsky P, Clemmensen I. Høgdall CK, et al. Acta Oncol. 1993;32(6):631-6. doi: 10.3109/02841869309092443. Acta Oncol. 1993. PMID: 8260181 Clinical Trial.

3

Determination of serum tetranectin: technical and clinical evaluation of three sandwich immunoassays.

Thougaard AV, Høgdall CK, Kjaer SK, Blaakaer J, Jaliashvili I, Christiansen M. Thougaard AV, et al. Among authors: hogdall ck. Clin Chim Acta. 1998 Aug 10;276(1):19-34. doi: 10.1016/s0009-8981(98)00092-8. Clin Chim Acta. 1998. PMID: 9760017

4

OVX1 radioimmunoassay results are dependent on the method of sample collection and storage.

Hogdall EV, Hogdall CK, Kjaer SK, Xu F, Yu Y, Bast RC, Blaakaer J, Jacobs IJ. Hogdall EV, et al. Among authors: hogdall ck. Clin Chem. 1999 May;45(5):692-4. Clin Chem. 1999. PMID: 10222361 No abstract available.

5

Distribution of p53 codon 72 polymorphisms in ovarian tumour patients and their prognostic significance in ovarian cancer patients.

Høgdall EV, Høgdall CK, Christensen L, Glud E, Blaakaer J, Bock JE, Vuust J, Nørgaard-Pedersen B, Kjaer SK. Høgdall EV, et al. Among authors: hogdall ck. Anticancer Res. 2002 May-Jun;22(3):1859-64. Anticancer Res. 2002. PMID: 12168882

6

P53 autoantibodies in sera from Danish ovarian cancer patients and their correlation with clinical data and prognosis.

Høgdall EV, Høgdall CK, Blaakaer J, Heegaard NH, Glud E, Christensen L, Bock JE, Nørgaard-Pedersen B, Wiik A, Kjaer SK. Høgdall EV, et al. Among authors: hogdall ck. APMIS. 2002 Aug;110(7-8):545-53. doi: 10.1034/j.1600-0463.2002.11007805.x. APMIS. 2002. PMID: 12390412

7

K-ras alterations in Danish ovarian tumour patients. From the Danish "Malova" Ovarian Cancer study.

Høgdall EV, Høgdall CK, Blaakaer J, Christensen L, Bock JE, Vuust J, Glud E, Kjaer SK; Danish "Malova" Ovarian Cancer Study. Høgdall EV, et al. Among authors: hogdall ck. Gynecol Oncol. 2003 Apr;89(1):31-6. doi: 10.1016/s0090-8258(03)00005-2. Gynecol Oncol. 2003. PMID: 12694651

8

Distribution of HER-2 overexpression in ovarian carcinoma tissue and its prognostic value in patients with ovarian carcinoma: from the Danish MALOVA Ovarian Cancer Study.

Høgdall EV, Christensen L, Kjaer SK, Blaakaer J, Bock JE, Glud E, Nørgaard-Pedersen B, Høgdall CK. Høgdall EV, et al. Among authors: hogdall ck. Cancer. 2003 Jul 1;98(1):66-73. doi: 10.1002/cncr.11476. Cancer. 2003. PMID: 12833457 Free article.

9

High plasma YKL-40 level in patients with ovarian cancer stage III is related to shorter survival.

Høgdall EV, Johansen JS, Kjaer SK, Price PA, Christensen L, Blaakaer J, Bock JE, Glud E, Høgdall CK. Høgdall EV, et al. Among authors: hogdall ck. Oncol Rep. 2003 Sep-Oct;10(5):1535-8. Oncol Rep. 2003. PMID: 12883737

10

Evaluation of a polymorphism in intron 2 of the p53 gene in ovarian cancer patients. From the Danish "Malova" Ovarian Cancer Study.

Høgdall EV, Kjaer SK, Glud E, Christensen L, Blaakaer J, Vuust J, Bock JE, Norgaard-Pedersen B, Hogdall CK. Høgdall EV, et al. Among authors: hogdall ck. Anticancer Res. 2003 Jul-Aug;23(4):3397-404. Anticancer Res. 2003. PMID: 12926080

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

354 results

Search Page

Filters